Blume Capital Management, Inc. Boston Scientific Corp Transaction History
Blume Capital Management, Inc.
- $431 Million
- Q1 2025
A detailed history of Blume Capital Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Blume Capital Management, Inc. holds 9 shares of BSX stock, worth $941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$941% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,830Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$14.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.75 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.82 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.47 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $150B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...